NASDAQ:FBRX

Forte Biosciences Stock News

etoro logo Buy FBRX
*Your capital is at risk
$76.98
+0.450 (+0.588%)
At Close: Jul 30, 2026
TORRANCE, Calif.--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, will be providing 4Q and full year 2020 results and provide
TORRANCE, Calif.--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as
FB-401 is a unique approach to atopic dermatitis containing three strains of bacteria that have shown the ability to induce tissue repair and reduce inflammation. FB-401 may present efficacy and safet
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of an equity ind
Hours after blocking a New York Post article from being shared in tweets and direct messages, raising an outcry from many, Twitter Inc. late Wednesday...

Facebook to ban most anti-vaccination ads

09:00pm, Tuesday, 13'th Oct 2020
Facebook says it will ban ads on its platform that discourage vaccinations — with an exception carved out for ads about government vaccine policies.
Stifel Financial Corp increased its position in shares of FB Financial Corp (NYSE:FBK) by 3.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 29,456 shares of
Public Employees Retirement System of Ohio boosted its holdings in FB Financial Corp (NYSE:FBK) by 16.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securit
Analysts expect that FB Financial Corp (NYSE:FBK) will announce sales of $135.25 million for the current quarter, Zacks reports. Four analysts have provided estimates for FB Financial’s earnings, wi
Issues on the docket include copyright law, regulations tied to prescriptions and unsolicited text messages.

Best shower heads 2020 | CNN Underscored

08:36pm, Tuesday, 15'th Sep 2020
AstraZeneca announces encouraging results from OSTRO trial. Forte Biosciences reports positive data for FB-401.
Forte Biosciences, Inc. (NASDAQ: FBRX) (www.fortebiorx.com), a clinical-stage biopharmaceutical company, today announced the issuance of an equity ind
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE